Your institution may have access to this item. Find your institution then sign in to continue.
Title
Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
Authors
Beral, Valerie; Reeves, Gillian; Bull, Diana; Green, Jane; Million Women Study Collaborators
Abstract
Although breast cancer risk is greater in users of estrogen-progestin than estrogen-only formulations of menopausal hormonal therapy, reports on their effects have been somewhat inconsistent. We investigated whether the timing of these therapies affected breast cancer incidence.
Publication
Journal of the National Cancer Institute, 2011, Vol 103, Issue 4, p296